注册 | 登录 | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

jyuh's hd [658 articles]

当前文献位于 jyuh's 文献库 标签分类为 hd. You can also see everyone's hd.
  • Effect of Angiotensin Receptor Blockers on Cardiovascular Events in Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (22 July 2008)
    by Hiromichi Suzuki, Yoshihiko Kanno, Soichi Sugahara, Naofumi Ikeda, Junko Shoda, Tsuneo Takenaka, Tsutomu Inoue, Ryuichiro Araki
    posted to rct hd cv arb by jyuh on 2008-08-06 09:19:29 as **
  • Disordered Mineral Metabolism in Hemodialysis Patients: An Analysis of Cumulative Effects in the Hemodialysis (HEMO) Study.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (25 July 2008)
    by Ron Wald, Mark J J Sarnak, Hocine Tighiouart, Alfred K K Cheung, Andrew S S Levey, Garabed Eknoyan, Dana C C Miskulin
    posted to rct p hd ca by jyuh on 2008-08-06 07:36:13 as **
  • Management of hypertension in hemodialysis patients
    Hemodialysis International, Vol. 10, No. 3. (July 2006), pp. 241-248.
    by Rajiv Agarwal
    posted to hd bp by jyuh on 2008-07-20 12:41:43 as **
  • Diagnosing Hypertension by Intradialytic Blood Pressure Recordings.
    Clinical journal of the American Society of Nephrology : CJASN (21 May 2008)
    by Rajiv Agarwal, Tesfamariam Metiku, Getachew G G Tegegne, Robert P P Light, Zerihun Bunaye, Dagim M M Bekele, Ken Kelley
    posted to hd bp by jyuh on 2008-07-20 12:35:12 as **
  • Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
    Journal of the American Society of Nephrology : JASN, Vol. 18, No. 3. (March 2007), pp. 975-984.
    by DW Coyne, T Kapoian, W Suki, AK Singh, JE Moran, NV Dahl, AR Rizkala,
    posted to iron hd anemia by jyuh on 2008-07-20 11:49:16 as **
  • Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003
    Hemodialysis International, Vol. 11, No. 4. (October 2007), pp. 442-447.
    by Craig A Solid, Robert N Foley, David T Gilbertson, Allan J Collins
    posted to hospitalization hd anemia by jyuh on 2008-07-16 11:16:41 as **
  • Is low-frequency distribution of TGF-beta genotype associated with increased risk for end-stage renal disease?
    DNA and cell biology, Vol. 26, No. 3. (March 2007), pp. 172-177.
    by RD Mittal, PK Manchanda
    posted to tgfb snp hd by jyuh on 2008-07-15 16:37:22 as **
  • Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
    Clinica chimica acta; international journal of clinical chemistry, Vol. 370, No. 1-2. (August 2006), pp. 152-157.
    by PK Manchanda, A Kumar, A Kaul, RD Mittal
    posted to tnf snp hd by jyuh on 2008-07-15 16:36:23 as **
  • Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients.
    Kidney international, Vol. 66, No. 1. (July 2004), pp. 419-427.
    by M Rao, D Guo, BL Jaber, H Tighiouart, BJ Pereira, VS Balakrishnan,
    posted to tgfb snp hd cv by jyuh on 2008-07-15 16:25:00 as **
  • Gene Polymorphism Association Studies in Dialysis: Cardiovascular Disease
    Seminars in Dialysis, Vol. 18, No. 3. (May 2005), pp. 217-225.
    by Madhumathi Rao, Bertrand L Jaber, Vaidyanathapuram S Balakrishnan
    posted to snp hd cv by jyuh on 2008-07-15 16:22:44 as **
  • Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 39, No. 5. (May 2002), pp. 1032-1039.
    by T Nakamura, K Saionji, Y Hiejima, H Hirayama, K Tago, H Takano, M Tajiri, K Hayashi, M Kawabata, M Funamizu, Y Makita, A Hata
    posted to snp mthfr japan hd by jyuh on 2008-07-15 11:24:14 as **
  • Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 22, No. 7. (July 2007), pp. 2020-2026.
    by M Kalousová, M Jáchymová, O Mestek, M Hodková, M Kazderová, V Tesar, T Zima
    posted to snp rage hd by jyuh on 2008-07-14 11:25:58 as **
  • Mendelian randomization: a new approach to studying epidemiology in ESRD.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 47, No. 2. (February 2006), pp. 332-341.
    by C Zoccali, A Testa, B Spoto, G Tripepi, F Mallamaci
    posted to mendelian hd by jyuh on 2008-07-14 05:20:59 as **
  • Association of serum fetuin-A levels with mortality in dialysis patients.
    Kidney international, Vol. 72, No. 2. (July 2007), pp. 202-207.
    by MM Hermans, V Brandenburg, M Ketteler, JP Kooman, FM van der Sande, EW Boeschoten, KM Leunissen, RT Krediet, FW Dekker,
    posted to mortality hd fetuin cv calcification by jyuh on 2008-07-14 03:04:00 as **
  • The John F. Maher Award Recipient Lecture 2006. The continuum of chronic kidney disease and end-stage renal disease: challenges and opportunities for chronic peritoneal dialysis in the United States.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, Vol. 27, No. 2. (r 2007), pp. 125-130.
    by R Mehrotra
    posted to pd hd ckd by jyuh on 2008-07-14 03:02:06 as **
  • Poor correlation between coronary artery calcification and obstructive coronary artery disease in an end-stage renal disease patient
    Hemodialysis International, Vol. 12, No. 1. (January 2008), pp. 16-22.
    by Li-Li Tong, Rajnish Mehrotra, David M Shavelle, Matthew Budoff, Sharon Adler
    posted to hd calcification cad by jyuh on 2008-07-14 02:58:12 as **
  • Haplotype of signal transducer and activator of transcription 3 gene predicts cardiovascular disease in dialysis patients.
    Journal of the American Society of Nephrology : JASN, Vol. 17, No. 8. (August 2006), pp. 2285-2292.
    by L Zhang, WH Kao, Y Berthier-Schaad, Y Liu, L Plantinga, BG Jaar, N Fink, N Powe, MJ Klag, MW Smith, J Coresh
    posted to stat snp hd cv by jyuh on 2008-07-11 14:23:25 as **
  • Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 46, No. 1. (July 2005), pp. 78-85.
    by Y Liu, Y Berthier-Schaad, NE Fink, MD Fallin, RP Tracy, MJ Klag, MW Smith, J Coresh
    posted to snp hd fibrinogen cv by jyuh on 2008-07-11 14:23:09 as **
  • Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 37, No. 3. (March 2001), pp. 564-572.
    by K Kalantar-Zadeh, BR Don, RA Rodriguez, MH Humphreys
    posted to mortality iron hd by jyuh on 2008-07-11 11:25:55 as **
  • Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study
    Kidney International, Vol. 67, No. 3. (March 2005), 1179.
    by Eric W Young, Justin M Albert, Sudtida Satayathum, David A Goodkin, Ronald L Pisoni, Takashi Akiba, Tadao Akizawa, Kiyoshi Kurokawa, Jurgen Bommer, Luis Piera, Friedrich K Port
    posted to p hd dopps ca by jyuh on 2008-07-10 03:28:56 as **
  • 5-Methyltetrahydrofolate Administration Is Associated with Prolonged Survival and Reduced Inflammation in ESRD Patients.
    American journal of nephrology, Vol. 28, No. 6. (30 June 2008), pp. 941-948.
    by Giuseppe Cianciolo, Gaetano La Manna, Luigi Colì, Gabriele Donati, Francesca D'Addio, Elisa Persici, Giorgia Comai, Marylou Wratten, Ada Dormi, Vilma Mantovani, Gabriele Grossi, Sergio Stefoni
    posted to mortality hd hcy by jyuh on 2008-07-10 03:23:53 as **
  • Serum Phosphate Levels and Risk of Infection in Incident Dialysis Patients.
    Clinical journal of the American Society of Nephrology : CJASN (18 June 2008)
    by Laura C C Plantinga, Nancy E E Fink, Michal L L Melamed, William A A Briggs, Neil R R Powe, Bernard G G Jaar
    posted to p infection hd by jyuh on 2008-07-10 03:22:31 as **
  • C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 49, No. 1. (January 2007), pp. 118-126.
    by L Zhang, WH Kao, Y Berthier-Schaad, L Plantinga, N Fink, MW Smith, J Coresh
    posted to snp hd cv crp by jyuh on 2008-07-10 03:19:34 as **
  • An Algorithm for the Physical Examination of Early Fistula Failure
    Seminars in Dialysis, Vol. 18, No. 4. (July 2005), pp. 331-335.
    by Gerald A Beathard
    posted to hd avf by jyuh on 2008-07-10 03:14:29 as **
  • Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
    Canadian journal of physiology and pharmacology, Vol. 86, No. 4. (April 2008), pp. 205-209.
    by G Perunicic-Pekovic, S Pljesa, Z Rasic-Milutinovic, S Stankovic, M Ilic, R Maletic
    posted to inflammation hd cytokine cv by jyuh on 2008-07-10 03:11:17 as **
  • Gene Polymorphism Association Studies in Dialysis: The Nutrition-Inflammation Axis
    Seminars in Dialysis, Vol. 18, No. 4. (July 2005), pp. 322-330.
    by Bertrand L Jaber, Vaidyanathapuram S Balakrishnan, Peter Stenvinkel, Roberto Pecoits-Filho, Bengt Lindholm
    posted to snp mia hd by jyuh on 2008-07-10 02:55:44 as **
  • Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 23, No. 5. (May 2008), pp. 1659-1665.
    by PL Lu, JC Tsai, YW Chiu, FY Chang, YW Chen, CF Hsiao, LK Siu
    posted to mrsa hd by jyuh on 2008-07-08 14:36:04 as **
  • Factors causing malnutrition in patients with chronic uremia,
    American Journal of Kidney Diseases, Vol. 33, No. 1. (January 1999), pp. 176-179.
    by William E Mitch, Bradley J Maroni
    posted to hd cachexia by jyuh on 2008-07-08 09:41:10 as **
  • Barriers to adequate protein nutrition among hemodialysis patients
    Journal of Renal Nutrition, Vol. 8, No. 4. (October 1998), pp. 179-187.
    by Ashwini R Sehgal, Janeen Leon, Jeanette A Soinski
    posted to nutrition hd by jyuh on 2008-07-08 09:38:35 as **
  • Psychosocial factors in dialysis patients
    Kidney Int, Vol. 59, No. 4. (April 2001), pp. 1599-1613.
    by Paul L Kimmel
    posted to psychiatry hd by jyuh on 2008-07-08 09:38:19 as **
  • Serum albumin measurement in dialysis patients: Should it be a measure of clinical performance?
    Journal of Renal Nutrition, Vol. 12, No. 3. (July 2002), pp. 145-147.
    by Alan S Kliger
    posted to hd albumin by jyuh on 2008-07-08 09:23:39 as **
  • Therapeutic effects of oral nutritional supplementation during hemodialysis
    Kidney Int, Vol. 62, No. 3. (2002), pp. 1054-1059.
    by Kayser Caglar, Lori Fedje, Rita Dimmitt, Raymond M Hakim, Yu Shyr, Alp T Ikizler
    posted to idn hd albumin by jyuh on 2008-07-08 09:22:09 as **
  • Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
    Blood purification, Vol. 25, No. 3. (2007), pp. 274-279.
    by H Terawaki, K Nakayama, Y Matsuyama, M Nakayama, T Sato, T Hosoya, S Era, S Ito
    posted to ros hd albumin by jyuh on 2008-07-08 08:04:18 as **
  • Establishment and Maintenance of Vascular Access in Incident Hemodialysis Patients: A Prospective Cost Analysis
    J Am Soc Nephrol, Vol. 16, No. 1. (1 January 2005), pp. 201-209.
    by Braden Manns, Marcello Tonelli, Serdar Yilmaz, Helen Lee, Kevin Laupland, Scott Klarenbach, Val Radkevich, Brendan Murphy
    posted to hd cost-effective avf by jyuh on 2008-07-08 07:50:49 as **
  • Cardiovascular disease in dialysis patients: do some antihypertensive drugs have specific antioxidant effects or is it just blood pressure reduction? Does antioxidant treatment reduce the risk for cardiovascular disease?
    Current opinion in nephrology and hypertension, Vol. 17, No. 1. (January 2008), pp. 99-105.
    by S Aslam
    posted to ros hd cv by jyuh on 2008-07-08 07:36:14 as **
  • Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias".
    Journal of the American Society of Nephrology : JASN, Vol. 16, No. 11. (November 2005), pp. 3371-3380.
    by T Greene, J Daugirdas, T Depner, M Allon, G Beck, C Chumlea, J Delmez, F Gotch, JW Kusek, N Levin, W Owen, G Schulman, R Star, R Toto, G Eknoyan,
    posted to ukm rct hd bias by jyuh on 2008-07-08 07:35:10 as **
  • Hemoglobin Variability: Random Fluctuation, Epiphenomenon, or Phenomenon?
    Seminars in Dialysis, Vol. 19, No. 3. (May 2006), pp. 257-259.
    by Berns, S Jeffrey, Fishbane, Steven
    posted to variability hd epo anemia by jyuh on 2008-07-08 07:05:18 as **
  • Hemoglobin variability: impact on anemia management practices.
    Nephrology nursing journal : journal of the American Nephrology Nurses' Association, Vol. 30, No. 4. (August 2003), pp. 456-459.
    by R Breiterman-White
    posted to variability hd epo anemia by jyuh on 2008-07-08 07:05:04 as **
  • Hemoglobin variability in epoetin-treated hemodialysis patients.
    Kidney international, Vol. 64, No. 4. (October 2003), pp. 1514-1521.
    by JS Berns, H Elzein, RI Lynn, S Fishbane, IS Meisels, PB Deoreo
    posted to variability hd epo anemia by jyuh on 2008-07-08 07:04:29 as **
  • Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients
    Nephrol. Dial. Transplant. (29 May 2008), gfn304.
    by Martin Tepel, Werner Hopfenmueller, Alexandra Scholze, Alexandra Maier, Walter Zidek
    posted to hd cv ccb by jyuh on 2008-07-08 05:45:57 as **
  • Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?
    Nephrol. Dial. Transplant. (25 February 2008), gfn038.
    by Charles A Herzog, Jeremy W Strief, Allan J Collins, David T Gilbertson
    posted to mortality hd cad by jyuh on 2008-07-08 05:42:01 as **
  • Effects of Atorvastatin on Lp(a) and Lipoprotein Profiles in Hemodialysis Patients
    Ann Pharmacother, Vol. 42, No. 1. (1 January 2008), pp. 9-15.
    by Melanie S Joy, Kimberly A Dornbrook-Lavender, Hyunsook Chin, Susan L Hogan, Cynthia Denu-Ciocca
    posted to statin lipid hd by jyuh on 2008-07-08 05:31:08 as **
  • The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study
    Nephrol. Dial. Transplant. (24 April 2008), gfn180.
    by My Svensson, Erik B Schmidt, Kaj A Jorgensen, Jeppe H Christensen
    posted to rct lipid hd fish-oil by jyuh on 2008-07-08 05:29:21 as **
  • Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
    N Engl J Med, Vol. 353, No. 3. (21 July 2005), pp. 238-248.
    by Christoph Wanner, Vera Krane, Winfried Marz, Manfred Olschewski, Johannes F Mann, Gunther Ruf, Eberhard Ritz, The
    posted to statin hd dm by jyuh on 2008-07-08 05:19:05 as **
  • Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality.
    The American journal of clinical nutrition, Vol. 87, No. 6. (June 2008), pp. 1860-1866.
    by M Watanabe, ME Suliman, AR Qureshi, E Garcia-Lopez, P Bárány, O Heimbürger, P Stenvinkel, B Lindholm
    posted to ros mortality inflammation hd by jyuh on 2008-07-08 04:51:50 as **
  • Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial
    Kidney Int, Vol. 60, No. 4. (October 2001), pp. 1498-1510.
    by Dana C Miskulin, Nicolaos V Athienites, Guofen Yan, Alice A Martin, Daniel B Ornt, John W Kusek, Klemens B Meyer, Andrew S Levey
    posted to rct hd comorbidity by jyuh on 2008-07-08 04:26:27 as **
  • Markers of inflammation, proteolysis, and apoptosis in ESRD.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 42, No. 6. (December 2003), pp. 1212-1220.
    by DS Raj, H Shah, VO Shah, A Ferrando, A Bankhurst, R Wolfe, PG Zager
    posted to inflammation hd catabolism apoptosis by jyuh on 2008-07-08 04:21:00 as **
  • Utility of the "Surprise" Question to Identify Dialysis Patients with High Mortality.
    Clinical journal of the American Society of Nephrology : CJASN (2 July 2008)
    by Alvin H H Moss, Jesse Ganjoo, Sanjay Sharma, Julie Gansor, Sharon Senft, Barbara Weaner, Cheryl Dalton, Karen Mackay, Beth Pellegrino, Priya Anantharaman, Rebecca Schmidt
    posted to mortality hd by jyuh on 2008-07-08 04:05:26 as **
  • Influence of oxidative stress and inflammation on rHuEPO requirements of hemodialysis patients with CRP values "in normal range".
    Transplantation proceedings, Vol. 39, No. 10. (December 2007), pp. 3035-3040.
    by E Tutal, S Sezer, A Bilgic, D Aldemir, S Turkoglu, O Demirel, N Ozdemir, M Haberal
    posted to ros inflammation hd epo crp by jyuh on 2008-07-08 04:03:58 as **
  • Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.
    Kidney international, Vol. 65, No. 4. (April 2004), pp. 1449-1460.
    by VS Balakrishnan, D Guo, M Rao, BL Jaber, H Tighiouart, RL Freeman, C Huang, AJ King, BJ Pereira,
    posted to snp hd cytokine albumin by jyuh on 2008-07-08 04:03:18 as **
    • ◇温馨提示◇本页的引用地址为： http://www.citeulike.org/user/jyuh/tag/hd

    Result page: 1 2 3 4 5 6 7 8 9 10 Next RIS BibTeX